ISLAMABAD: Pakistan on Friday called on the international community to classify the Majeed Brigade as an alias of the banned ...

Pakistan, having made unparalleled sacrifices in the global counter-terrorism arena, urged the international community to ...

George Mulligan, PhD, previews the FDA's ODAC meeting discussing the application of belantamab mafodotin-based combinations for the treatment of multiple myeloma.

A New York-based privately held real estate operator and investment management firm has purchased the Park Place student ...

The Baloch Liberation Army (BLA) has claimed responsibility for two attacks in Balochistan, killing 29 Pakistani soldiers. In ...

In a major development, the Balochistan Liberation Army (BLA) has launched a deadly attack on Pakistani military forces, ...

Police and government officials in southwestern Pakistan say that gunmen have opened fire on a passenger bus, killing at least three people and wounding seven others ...

The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).

GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom ...

Pierre Fabre leads global development of tab-cel, an innovative therapy for EBV+ PTLD, with ongoing trials and potential FDA ...